Nantahala Capital Management’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $412K | Sell |
|
|||||
|
2021
Q4 | $542K | Sell |
|
|||||
|
2021
Q3 | $1.04M | Sell |
|
|||||
|
2021
Q2 | $2.87M | Sell |
|
|||||
|
2021
Q1 | $4.16M | Sell |
|
|||||
|
2020
Q4 | $5.99M | Sell |
|
|||||
|
2020
Q3 | $7.32M | Hold |
|
|||||
|
2020
Q2 | $9.91M | Buy |
|
|||||
|
2020
Q1 | $4.51M | Buy |
|
|||||
|
2019
Q4 | $5.08M | Hold |
|
|||||
|
2019
Q3 | $4.2M | Hold |
|
|||||
|
2019
Q2 | $6.56M | Buy |
|
|||||
|
2019
Q1 | $6.49M | Sell |
|
|||||
|
2018
Q4 | $5.7M | Sell |
|
|||||
|
2018
Q3 | $11.4M | Buy |
|
|||||
|
2018
Q2 | $8.82M | Buy |
|
|||||
|
2018
Q1 | $1.72M | Sell |
|
|||||
|
2017
Q4 | $3.66M | Buy |
|